Seroprevalence of hepatitis C virus in the general population;Seroprevalencia del virus de la hepatitis C en la población general

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 20, Issue 2, 2002, Pages 64-67

  Chimeno, Ma Montserrat ^a,b   Chocarro, Ángel ^a   Brezmes, Purificación ^a   Ochoa, Carlos ^a   Pérez, José ^a  

^a HOSPITAL VIRGEN DE LA CONCHA   (Spain)

^b NONE   (Spain)

Author keywords

Epidemiology; Hepatitis C virus; Prevalence

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; HEPATITIS C; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; RURAL POPULATION; URBAN POPULATION;

ADOLESCENT; ADULT; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; RURAL POPULATION; SEROEPIDEMIOLOGIC STUDIES; URBAN POPULATION;

EID: 0347368254     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0213-005x(02)72743-2     Document Type: Article

References (33)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley AX, Houghton M. Isolation of cDNA clone derived from a blood-borne nonA, nonB viral hepatitis genome. Science 1989;224:359-62.
2. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH. An assay for circulating ontibodies to a major etiologia virus of human nonA, nonB hepatitis. Science 1989;224;362-4.
3. Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A, et al. Antibody to hepatitis C virus in posttransfusion hepatitis. Ann Intern Med 1991;114:277-81.
4. Esteban JI, González A, Hernández JM, Viladomiu L, Sánchez C, López Talavera JC, et al. Evaluation of antibodies to hepatitis C in a study of transfusion-associated hepatitis. N Engl J Med 1990;323:1107-12.
5. Sánchez Tapias JM, Barrera JM, Costa J, Ercilla MG, Parés A, Comalrrena L, et al. Hepatitis C virus infection in patients with nonalcoholic chronic liver disease. Ann Intern Med 1990;112:921-4.
6. Seef LB. Natural history of hepatitis C. Hepatology 1997;26(Suppl 1):21S-8S.
7. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991;14:969-74.
8. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-40.
9. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
10. Castells L, Vargas V, González A, Esteban J, Esteban R, Guardias J. Long interval between HCV infection and development of hepatocellular carcinoma. Liver 1995;15:159-63.
11. Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia. Transfusion 1994;34:135-7.
12. Llibre JM, Bartolí M, Berrocal M, González M. Seroprevalencia del virus de la hepatitis C en adictos a drogas por via parenteral. Med Clin (Barc) 1992;99:675-6.
13. Rumi MG, Colombo M, Gringeri A, Mannucci PM. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. Ann Intern Med 1990;112:379-80.
14. Ghany MG, Leissinger C, Lagier R, Sánchez-Pescador R, Lok AS. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996;41:1265-72.
15. Kjoro K, Frolano SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hipogammaglobulinemia after treatment with contamined immune globuline. N Engl J Med 1994;331:1607-11.
16. Sacristán B, Gastañares MI, Elena A, Sacristán M, Barcenilla J, García JC, et al. Infección por el virus de la hepatitis C. Estudio seroepidemiológico en población general de La Rioja. Med Clin (Barc) 1996;107:331-5.
17. Alter MJ, Krusson-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
18. Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of sample size in health studies. World Health Organization. Chichester: John Wiley & Sons Ltd., 1990.
19. Suárez A, Viejo G, Navascues CA, García R, Díaz G, Saro C, et al. Prevalencia de marcadores frente a los virus A, B y C de la hepatitis en la población de Gijón entre 26 y 65 años de edad. Gastroenterol Hepatol 1997;20:347-52.
20. Bellentani S, Tiribelli G, Saccoccio G, Sodde M, Fratti N, De Martín C, et al. Prevalence of chronic liver disease in the general population of Northerm Italy: the Dionysos study. Hepatology 1994;2:1442-9.
21. Viral Hepatitis Prevention Board. Consensus Statement. Viral Hepatitis 1995;4:5-10.
22. Van Damme P, Vellinga A. Epidemiology of hepatitis B and C in Europe. Acta Gastroenterol Belg 1998;61:175-82.
23. Santos A, Carvalho A, Bento D, Sá R, Tomaz J, Rodríguez V, et al. Epidemiologia da hepatite C na regiâo centro de Portugal. Prevalencia do Anti-VHC na populacâo do distrito de Coimbra. Acta Med Port 1993;6:567-72.
24. Davis GL. Hepatitis C virus infection among health care workers. JAMA 1996;275:1474.
25. Germanaud J, Barthez JP, Causse X. The occupational risk of hepatitis C infection among hospital employees. Am J Public Health 1994;84:122.
26. Sodeyama T, Kiyosawa K, Urushihara A, Matsumoto A, Tanaka E, Furuta S, et al. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch Intern Med 1993;153:1565-72.
27. García-Bengoechea M, Emparanza J, Sarriugarte A, Cortés A, Vega JL, González F, et al. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroenterol Hepatol 1995;7:237-41.
28. Bruguera M. La hepatitis C, otra plaga. Med Clin (Barc) 1994;103:615-6.
29. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(Suppl 1):62S-5S.
30. Schneeberger PM, Keur I, van der Vliet W, van Hoek K, Boswijk H, van Loon AM, et al. Hepatitis C virus infections in Dialysi Centers in The Netherlands: a National Survey by serological and molecular methods. J Clin Microbiol 1998;36:1711-5.
31. Nousbaum JB, Pol S, Nalpas B, Laudais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France an Italy. Collaborative study group. Ann Intern Med 1995;122:161-8.
32. Alonso P, Orduña A, San Miguel A, Gutiérrez MP, Lorenzo B, Eiros JM, et al. Variantes del virus de la hepatitis C en diferentes grupos de riesgo. Estudio comparative de un método de genotipificación y otro de serotipificación. Enferm Infecc Microbiol Clin 1998;16:111-7.
33. Powlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, et al. Relationship between hepatitis C virus genotyping and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;171:1607-10.